APO RESEARCH · REPORT
Pruritus Therapeutics
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Product & engineering
Understand the product.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Selected research
Industry Growth & Trends
Global Pruritus Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, the global Pruritus Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Pruritus Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pruritus Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pruritus Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pruritus Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pruritus Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pruritus Therapeutics Market by Company
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Pruritus Therapeutics Segment by Type
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Pruritus Therapeutics Segment by Application
External Use
Oral
Injection
Pruritus Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pruritus Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antihistamines
- Corticosteroids
- Calcineurin Inhibitors
- Others
Applications
- External Use
- Oral
- Injection
Companies covered
- J&J
- Abbott
- Amgen
- LEO Pharma
- Novartis
- Bayer
- Pfizer
- UCB Pharma
- GlaxoSmithKline
- Galderma
- Huapont
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pruritus Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pruritus Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Pruritus Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Pruritus Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Pruritus Therapeutics Market Size (2021-2032)
- 1.5.1 North America Pruritus Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pruritus Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pruritus Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pruritus Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pruritus Therapeutics Market Size Growth Rate (2021-2032)
2 Pruritus Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Antihistamines
- 2.1.2 Corticosteroids
- 2.1.3 Calcineurin Inhibitors
- 2.1.4 Others
- 2.2 Global Pruritus Therapeutics Market Size by Type
- 2.2.1 Global Pruritus Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pruritus Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pruritus Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pruritus Therapeutics Market Size by Regions
- 2.3.1 North America Pruritus Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pruritus Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pruritus Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pruritus Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pruritus Therapeutics Market Size Breakdown by Type (2021-2026)
3 Pruritus Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 External Use
- 3.1.2 Oral
- 3.1.3 Injection
- 3.2 Global Pruritus Therapeutics Market Size by Application
- 3.2.1 Global Pruritus Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pruritus Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pruritus Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pruritus Therapeutics Market Size by Regions
- 3.3.1 North America Pruritus Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pruritus Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pruritus Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pruritus Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pruritus Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pruritus Therapeutics Industry Trends
- 4.2 Pruritus Therapeutics Industry Drivers
- 4.3 Pruritus Therapeutics Industry Opportunities and Challenges
- 4.4 Pruritus Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pruritus Therapeutics Revenue (2021-2026)
- 5.2 Global Pruritus Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pruritus Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Pruritus Therapeutics Company, Product Type & Application
- 5.5 Global Pruritus Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pruritus Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Pruritus Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 J&J
- 6.1.1 J&J Company Information
- 6.1.2 J&J Business Overview
- 6.1.3 J&J Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 J&J Pruritus Therapeutics Product Portfolio
- 6.1.5 J&J Recent Developments
- 6.2 Abbott
- 6.2.1 Abbott Company Information
- 6.2.2 Abbott Business Overview
- 6.2.3 Abbott Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Abbott Pruritus Therapeutics Product Portfolio
- 6.2.5 Abbott Recent Developments
- 6.3 Amgen
- 6.3.1 Amgen Company Information
- 6.3.2 Amgen Business Overview
- 6.3.3 Amgen Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Amgen Pruritus Therapeutics Product Portfolio
- 6.3.5 Amgen Recent Developments
- 6.4 LEO Pharma
- 6.4.1 LEO Pharma Company Information
- 6.4.2 LEO Pharma Business Overview
- 6.4.3 LEO Pharma Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
- 6.4.5 LEO Pharma Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Novartis Pruritus Therapeutics Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Bayer
- 6.6.1 Bayer Company Information
- 6.6.2 Bayer Business Overview
- 6.6.3 Bayer Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bayer Pruritus Therapeutics Product Portfolio
- 6.6.5 Bayer Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pfizer Pruritus Therapeutics Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 UCB Pharma
- 6.8.1 UCB Pharma Company Information
- 6.8.2 UCB Pharma Business Overview
- 6.8.3 UCB Pharma Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
- 6.8.5 UCB Pharma Recent Developments
- 6.9 GlaxoSmithKline
- 6.9.1 GlaxoSmithKline Company Information
- 6.9.2 GlaxoSmithKline Business Overview
- 6.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
- 6.9.5 GlaxoSmithKline Recent Developments
- 6.10 Galderma
- 6.10.1 Galderma Company Information
- 6.10.2 Galderma Business Overview
- 6.10.3 Galderma Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Galderma Pruritus Therapeutics Product Portfolio
- 6.10.5 Galderma Recent Developments
- 6.11 Huapont
- 6.11.1 Huapont Company Information
- 6.11.2 Huapont Business Overview
- 6.11.3 Huapont Pruritus Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Huapont Pruritus Therapeutics Product Portfolio
- 6.11.5 Huapont Recent Developments
7 North America
- 7.1 North America Pruritus Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pruritus Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Pruritus Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pruritus Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pruritus Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Pruritus Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pruritus Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pruritus Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pruritus Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pruritus Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pruritus Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Pruritus Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pruritus Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pruritus Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pruritus Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst